543731-16-4Relevant articles and documents
HYDROGENATION PROCESS OF OXIME DERIVATIVES
-
Page/Page column 27; 29, (2020/06/01)
The present invention relates to a novel process for the iridium-catalysed hydrogenation of oximes. The invention also relates to novel iridium catalysts for use in the iridium-catalysed hydrogenation of oximes and to processes of preparation of these cat
One-pot synthesis of alkoxyamine derivatives by reductive alkoxyamination with a 2-picoline-borane complex
Kawase, Yasushi,Yamagishi, Takehiro,Kutsuma, Teruo,Ueda, Kimio,Iwakuma, Takeo,Nakata, Tadashi,Yokomatsu, Tsutomu
experimental part, p. 463 - 470 (2009/06/08)
Reduction of oxime ethers with a 2-picoline-borane complex was examined to give alkoxyamine derivatives. The reduction was found to proceed in the presence of aqueous HCl in MeOH-AcOH. The method was extended to one-pot synthesis of alkoxyamine derivative
Intramolecular catalytic Friedel-Crafts reactions with allenyl cations for the synthesis of quinolines and their analogues
Ishikawa, Teruhiko,Manabe, Shinobu,Aikawa, Toshiaki,Kudo, Takayuki,Saito, Seiki
, p. 2361 - 2364 (2007/10/03)
(Equation Presented) This paper describes a novel method to synthesize a quinoline backbone by incorporating allenyl cations into a catalytic intramolecular Friedel-Crafts reaction. The initial products were isomerized and aromatized upon treatment with acid and base, respectively, to give quinolines. The basic concept also proved to be promising for 1-benzazepine, 1-benzazocine, or isoquinoline synthesis.
HIV Integrase inhibitors
-
, (2008/06/13)
The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the following formula, or a tautomer of said compound, or a pharmaceutically acceptable salt, solvate or prodrug thereof: wherein R1, R2 and B1 are as defined herein.